10-Q Impact 7/10 Earnings

$EHSI · Elite Health Systems Inc.

November 20, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Elite Health Systems Inc. filed its 10-Q for the quarter ended September 30, 2026. Revenue was $1,276,000 (up from $0 a year earlier) driven by the PSS acquisition and Medicare Advantage member onboarding, but the net loss widened to $1,486,000 from $1,161,000. Cash and cash equivalents fell to $740,000 from $3,758,000 at year-end 2025, and the filing discloses a going-concern risk with an accumulated deficit of $16,561,000.

  • Q3 revenue of $1,276,000 versus $0 in the prior-year quarter.
  • Nine-month net loss of $4,312,000 versus $2,026,000 a year earlier.
  • Cash fell to $740,000 from $3,758,000 at December 31, 2025.
  • Accumulated deficit reached $16,561,000 at September 30, 2026.
  • PSS contributed $1,097,000 of Q3 revenue, all from related parties.
PeriodQ3 FY2026
Revenue$1.3M
EPS$(0.05)
Net income$(1.5M)
Gross margin10.1%
Op. margin-98.5%

Price data unavailable.

A micro-cap Medicare Advantage entrant is burning cash rapidly with going-concern risk and related-party revenue concentration.

A newly licensed Medicare Advantage plan burning cash while onboarding members, with revenue heavily dependent on related-party PSS customers.

Going-concern doubt: $740,000 cash against a $4,312,000 nine-month net loss and reliance on equity sales to fund operations. PSS revenue of $1,097,000 in Q3 comes entirely from related parties tied to CEO Dr. Jeereddi.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →